In clinical practice cystitis resulting from systemic administration of cyclophosphamide may be life threatening or fatal. In a retrospective study of 444 patients with gynmcological tumours treated with cyclophosphamide, 101 patients developed overt cystitis and 10 of these patients died from causes directly attributable to the cystitis (Spechter 1965) .
The histological changes of cyclophosphamide cystitis consist of edema of the bladder wall, infiltration with polymorphonuclear leukocytes and submucosal hiemorrhages from dilated thin walled vessels (Fontana-Donatelli 1963 ).
An Experimental Model of Cyclophosphamide Cystitis
All of the experiments were conducted with adult female Wistar rats of the Royal Postgraduate Medical School strain. Cystitis was diagnosed by histological examination of heematoxylin and eosin stained sections of the bladders removed at autopsy. Only when all of the changes described were observed was cystitis diagnosed.
To determine the dose and route of administration of cyclophosphamide which produced cystitis four groups of five rats were used. Individual rats of the first group were given a single intravenous injection of 50, 100, 150, 200 or 250 mg/kg body weight, and those in the second group received similar doses of cyclophosphamide given by intraperitoneal injection. Individual rats of the third group were given three consecutive daily intravenous injections of 50, 100, 150, 200 or 250 mg/kg body weight of cyclophosphamide, and those in the fourth group received the same dosage schedule given intraperitoneally.
All of the rats that received a total dose of cyclophosphamide that was more than 200 mg/kg body weight died within six days of the initial injection. All of the surviving rats developed cystitis but those given intraperitoneal injections of cyclophosphamide showed chemical peritonitis which complicated the histological diagnosis of cystitis. Further experiments were therefore performed using rats that were given a single intravenous injection of cyclophosphamide 100 mg/kg body weight.
To determine the interval between cyclophosphamide administration and the maximal histological changes of cystitis, 16 rats were killed 2 hours to 16 days after injection of the drug. It was found that by 8 hours the effect was maximal. The reproducibility of this effects was confirmed in 10 rats that were killed 8 hours after a single intravenous injection of 100 mg/kg body weight for all showed the florid change of cystitis, and in the following experiments cyclophosphamide cystitis was induced using this protocol.
Acetylcysteine and Cyclophosphamide Cystitis Phillips et al. (1961) showed the activated metabolites of cyclophosphamide had a direct effect on the urinary bladder mucosa of dogs. Previous observations (Thompson 1962 , Bari 1968 ) have shown that compounds with free sulphydryl radicals like acetylcysteine, inactivate alkylating agents and protect against radiation injury.
Acetylcysteine is used in the treatment of sputum retention in man. It is not toxic (Lorber 1967 , Lorber & Hollcraft 1972 and does not impair the cytotoxic effects of cyclophosphamide (Botta et al. 1973 , Kline et al. 1973 ). Primack (1971) has shown in dogs that topical application of acetylcysteine to the bladder mucosa prevented cyclophosphamide cystitis and recently Botta et al. (1973) reported that oral acetylcysteine had some effect on cyclophosphamide cystitis in rats.
We therefore studied the effects of parenteral acetylcysteine on cyclophosphamide cystitis in rats. Four groups of 6 rats were used and cyclophosphamide was given to all of them. Two groups were given 100 mg/kg body weight of acetylcysteine intravenously 30 minutes before or after cyclophosphamide. Two other groups were controls and 1 ml of intravenous normal saline was given instead of acetylcysteine. Eight hours after cyclophosphamide all rats were killed and bladders histologically examined for cystitis.
All of the control rats given cyclophosphamide and saline had cystitis, but none of the rats given acetylcysteine before or after cyclophosphamide developed cystitis (Fig 1) .
To investigate the effects of acetylcysteine on developing cyclophosphamide cystitis 24 rats were used. Two rats were given cyclophosphamide alone and two were given only acetylcysteine; the remaining 20 rats were given cyclophosphamide and each received intravenous acetylcysteine 100 mg/kg body weight given 1 hour before to 6 hours after cyclophosphamide. No cystitis developed when the interval between cyclophosphamide and acetylcysteine was less than 2 hours. Cystitis in rats receiving acetylcysteine 2-6 hours after cyclophosphamide was proportional to the interval between cyclophosphamide and acetylcysteine. The diagnosis of outflow tract obstruction due to prostatic enlargement can sometimes be difficult, for the symptoms and signs are often misleading and incompletely explained by the usual clinical and radiological investigations. The methods that are now available for the urodynamic evaluation of vesicourethral function provide a quantitative assessment of the degree of obstruction which can be used to distinguish between disorders due to mechanical obstruction and other lesions affecting bladder function.
Urodynamics in the

Patients
During the past two years, 55 male patients with a presumptive diagnosis of prostatic obstruction were investigated in the urodynamic clinic. Their ages ranged from 43 to 82 years. The patients were divided into three groups on the basis of their clinical presentation.
Group 1 consisted of 25 patients in whom the symptoms and signs were atypical of benign prostatic hypertrophy. They had symptoms referable to the lower urinary tract but the clinical and radiological findings were equivocal. 'Present address: Royal Naval Hospital, Haslar
